Revolutionizing aneurysm and AVM treatment and research
Programs that Save Lives
- ALS and Neuromuscular Disease
- Alzheimer’s and Dementia
- Aneurysm and AVM
- Barrow Innovation Center
- Barrow Neuroplex
- Ivy Brain Tumor Center
- Cleft and Craniofacial
- Concussion and Brain Injury
- Migraine and Headache
- Neuro-Rehabilitation and Neuro-Robotics
- Parkinson’s and Movement Disorders
- Sonntag Spine Center
- Petznick Stroke Center
Brain aneurysms and arteriovenous malformations (AVMs) are often thought of by patients as ticking time bombs in their brains. A brain aneurysm is a weakness in a blood vessel in the brain that balloons and fills with blood. If it bursts, the outcome can be deadly.
AVMs, a tangle of deformed arteries and veins, are less common than aneurysms but are more deadly. Half of all AVM hemorrhages are fatal. Young people are disproportionately affected. AVM ruptures occur most often in people between 15 and 20 years old. Half of those who suffer burst aneurysms are under 50.
These brain bursts are a serious problem. Ruptures happen frequently and the need for more research into treatment techniques is critical to lowering death and disability rates.
To help change the outcome for those affected by these conditions, Barrow accepts challenges by taking on patients who are deemed ‘inoperable’ by others. See what we achieved in 2019 by downloading the Impact Report below.
2019 Barrow Aneurysm & AVM Research Impact Report
Transforming lives through cutting-edge aneurysm and AVM research
The Barrow Aneurysm and Arteriovenous Malformation Research Center performs research to better understand the biology of aneurysms and AVMs to improve the quality of life for people affected by these neurovascular diseases. Understanding the genetics helps doctors find ways to better treat or prevent complications.
Some AVMs are small and can be easily removed but others are so large they’re impossible to treat. Unraveling the biology behind these inoperable AVMs can lead to the development of new, noninvasive and effective treatments. Drugs can help to reduce the risk of a ruptured aneurysm for those who cannot undergo surgery. With your help, we can determine the biology that makes an aneurysm grow and develop drugs to counter it.
Providing hope to patients and families
Dr. Lawton, president and CEO of Barrow and director of the Barrow Aneurysm and Arteriovenous Malformation Research Center, leads the effort in transforming the lives of patients with neurovascular diseases. He conducts research into the formation, underlying genetics, hemodynamics, rupture and computational modeling of brain aneurysms and AVMS.
We have the world’s leading specialist championing this work; Dr. Lawton has treated over 5,000 aneurysms, 875 AVMs and 1,000 cavernous malformations.
With your support Dr. Lawton and the top-notch Barrow team can continue to make progress into new treatments and cures, and save more lives – like Kristian’s.